Plenary Speakers

Topic: Light Microscopy

Monday, March 25, 8:00 AM - 9:00 AM

Erika

Erika Holzbaur, PhD
William Maul Measey Professor of Physiology
University of Pennsylvania, Perelman School of Medicine

Erika Holzbaur is the William Maul Measey Professor of Physiology at the University of Pennsylvania Perelman School of Medicine.  She received her B.S. with High Honors in Chemistry and History from the College of William and Mary and her PhD in Biochemistry from Penn State. Her PhD thesis focused on the mechanochemistry of dynein, and her postdoctoral work at the Worcester Foundation investigated the regulation of cytoplasmic dynein and dynactin.  Holzbaur joined the faculty at Penn in 1992, where she is a tenured professor and directs the graduate program in Cell Biology, Physiology & Metabolism. The Holzbaur lab studies molecular motors, cytoskeletal and organelle dynamics, axonal transport, autophagy, and neurodegeneration using live cell and single molecule approaches.  Dr. Holzbaur has received a Porter Fellowship, the NINDS Javits Award, the Stanley N. Cohen Biomedical Research Award and the Jane M. Glick Graduate Student Teaching Award from Penn. She is a Lifetime Fellow of the ASCB and serves on multiple editorial boards, including Cell and JCB.  

Understanding the Science of Branding when Branding for Science

Sunday, March 24, 1:00 PM - 2:00 PM

Chris

Chris Dillon
Communications Director
UF ICBR

Chris Dillon is the Communications Director for the University of Florida’s Interdisciplinary Center for Biotechnology Research (UF ICBR). Chris first arrived at the University of Florida in 2011, serving as the Communications Coordinator to the Vice Principal of Development & Alumni Affairs for the $1.72B Florida Tomorrow Campaign. The following year, he would go onto serve as Strategic Project Manager at the University of Florida Foundation with a focus on branding, development and UFF Board engagement. In 2016, he took over the communications department at UF ICBR, emphasizing the center’s rebranding project, website redesign and marketing efforts.
 

Big Data and Health

Sunday, March 24, 8:00 AM - 9:00 AM

Mike Snyder

Michael Snyder, PhD
Professor and Chair of Genetics
Director, Stanford Center for Genomics and Personalized Medicine

Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and within species. He has also combined different state-of–the-art “omics” technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a cofounder of several biotechnology companies, including Protometrix (now part of Life Tehcnologies), Affomix (now part of Illumina), Excelix, Personalis, Q Bio and he presently serves on the board of a number of companies.